Should modern imaging be part of remission criteria in rheumatoid arthritis?

被引：46

作者：

Haavardsholm, Espen A. ^{[1
]}

Lie, Elisabeth ^{[1
]}

Lillegraven, Siri ^{[1
]}

机构：

[1] Diakonhjemmet Hosp, Dept Rheumatol, N-0319 Oslo, Norway

来源：

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2012年 / 26卷 / 06期

关键词：

Rheumatoid arthritis; Remission; Magnetic resonance imaging; Ultrasonography; MODIFYING ANTIRHEUMATIC DRUGS; BONE-MARROW EDEMA; PREDICTS EROSIVE PROGRESSION; SMALL JOINT INVOLVEMENT; LOW DISEASE-ACTIVITY; 1-YEAR FOLLOW-UP; AMERICAN-COLLEGE; CLINICAL REMISSION; RHEUMATOLOGY/EUROPEAN LEAGUE; RADIOGRAPHIC PROGRESSION;

D O I：

10.1016/j.berh.2012.10.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

With recent improvements in the treatment of rheumatoid arthritis (RA), remission has become an achievable goal for a large proportion of RA patients, and remission is now a defined target in current RA guidelines. However, studies have shown that progression of radiographic joint damage may occur in clinical remission, regardless of the choice of remission definition. Subclinical inflammation detected by modern imaging techniques such as ultrasonography and magnetic resonance imaging is present in the majority of patients in clinical remission, and is associated with progressive joint damage and disease activity flare in these patients. This chapter aims to assess the importance of imaging findings in RA patients in clinical remission and to discuss the possible role of modern imaging in future remission criteria. (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：767 / 785

页数：19

共 136 条

[1] Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations
Aletaha, D.
Landewe, R.
Karonitsch, T.
Bathon, J.
Boers, M.
Bombardier, C.
Bombardieri, S.
Choi, H.
Combe, B.
Dougados, M.
Emery, P.
Gomez-Reino, J.
Keystone, E.
Koch, G.
Kvien, T. K.
Martin-Mola, E.
Matucci-Cerinic, M.
Michaud, K.
O'Dell, J.
Paulus, H.
Pincus, T.
Richards, P.
Simon, L.
Siegel, J.
Smolen, J. S.
Sokka, T.
Strand, V.
Tugwell, P.
van der Heijde, D.
van Riel, P.
Vlad, S.
van Vollenhoven, R.
Ward, M.
Weinblatt, M.
Wells, G.
White, B.
Wolfe, F.
Zhang, B.
Zink, A.
Felson, D.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (10) : 1360 - 1364
[2] The definition and measurement of disease modification in inflammatory rheumatic diseases
Aletaha, D
Smolen, JS
[J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2006, 32 (01) : 9 - +
[3] Remission and active disease in rheumatoid arthritis - Defining criteria for disease activity states
Aletaha, D
Ward, MM
Machold, KP
Nell, VPK
Stamm, T
Smolen, JS
[J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : 2625 - 2636
[4] Aletaha D, 2006, CLIN EXP RHEUMAT S43, V24, pS
[5] Allaart CF, 2006, CLIN EXP RHEUMATOL, V24, pS77
[6] 'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis
Atar, Dan
Birkeland, Kare Inge
Uhlig, Till
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (04) : 629 - 630
[7] Evaluation of a Novel 7-Joint Ultrasound Score in Daily Rheumatologic Practice: A Pilot Project
Backhaus, M.
Ohrndorf, S.
Kellner, H.
Strunk, J.
Backhaus, T. M.
Hartung, W.
Sattler, H.
Albrecht, K.
Kaufmann, J.
Becker, K.
Soerensen, H.
Meier, L.
Burmester, G. R.
Schmidt, W. A.
[J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1194 - 1201
[8] Balsa A, 2004, J RHEUMATOL, V31, P40
[9] Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard
Balsa, Alejandro
de Miguel, Eugenio
Castillo, Concepcion
Peiteado, Diana
Martin-Mola, Emilio
[J]. RHEUMATOLOGY, 2010, 49 (04) : 683 - 690
[10] The development of the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas
Bird, P
Conaghan, P
Ejberg, B
McQueen, F
Lassere, M
Peterfy, C
Edmonds, J
Shnier, R
O'Connor, P
Haavardsholm, E
Emery, P
Genant, H
Ostergaard, M
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 8 - 10

← 1 2 3 4 5 6 7 8 9 10 →